Blood biomarkers may flag epilepsy patients at risk of sudden death
NCT ID NCT03419000
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether tiny molecules in the blood, called microRNAs, can identify epilepsy patients who have dangerous drops in oxygen during seizures. Researchers compared 50 drug-resistant epilepsy patients undergoing video-EEG monitoring, splitting them into those who had breathing problems during seizures and those who did not. The goal is to find a simple blood test that could predict risk of sudden unexpected death in epilepsy (SUDEP).
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a blood test that identifies epilepsy patients at higher risk of sudden unexpected death (SUDEP), enabling closer monitoring or preventive strategies.
What could go wrong
This is a small, early-stage observational study (75 participants) looking at biomarkers, not a treatment trial. The findings may not translate into a reliable clinical test or reduce SUDEP risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG RESISTANT EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospices Civils de Lyon
Bron, 69500, France
-
Service de Neurophysiologie Clinique Hôpital La Timone
Marseille, 13005, France